Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
05.01.26
/
50%
€20.00
Target price
05.01.27
€44.47
Performance (%)
-13.50%
Price
06.02.26
€20.00
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -13.50%. This prediction currently runs until 05.01.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | - | - |
| iShares Core DAX® | 0,46 % | -2,00 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % |
| iShares S&P 500 | -1,76 % | -3,67 % |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Guggenheim from $64.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€32.00
20.06.25
20.06.25
€55.59
20.06.26
20.06.26
-37.50%
06.02.26
06.02.26
